共 12 条
[2]
[Anonymous], BACT RISK CONTR STRA
[3]
Fecal Microbiota-based Therapeutics for Recurrent Clostridium difficile Infection, Ulcerative Colitis and Obesity
[J].
EBIOMEDICINE,
2016, 13
:37-45
[4]
Diagnosis and Treatment of Clostridium difficile Infection
[J].
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION,
2018, 320 (10)
:1031-1032
[7]
Ensuring the safe and effective FDA regulation of fecal microbiota transplantation
[J].
JOURNAL OF LAW AND THE BIOSCIENCES,
2015, 2 (02)
:396-415
[9]
U.S. Food & Drug Administration, 2016, ENF POL REG INV NEW
[10]
van Nood E, 2013, NEW ENGL J MED, V368, P2145, DOI [10.1056/NEJMoa1205037, 10.1056/NEJMc1303919]